We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
-6.84%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+258.3%
AUM
$1.41B
AUM Growth
-$133M
Cap. Flow
-$6.88M
Cap. Flow %
-0.49%
Top 10 Hldgs %
27.43%
Holding
296
New
14
Increased
84
Reduced
108
Closed
10

Top Buys

Rank Stock Value
1
TER icon
Teradyne
TER
+$6.28M
2
ADBE icon
Adobe
ADBE
+$4.16M
3
CRM icon
Salesforce
CRM
+$2.9M
4
INTC icon
Intel
INTC
+$2.5M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.5M

Sector Composition

Rank Sector Weight
1 Technology 24.67%
2 Healthcare 15.48%
3 Financials 8.49%
4 Industrials 8.12%
5 Consumer Discretionary 6.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
26
Johnson & Johnson
JNJ
$625B
$17.6M 1.25%
99,443
+704
+0.7% +$120K
CRM icon
27
Salesforce
CRM
$158B
$17M 1.21%
80,126
+13,492
+20% +$2.9M
SYK icon
28
Stryker
SYK
$130B
$16.8M 1.19%
62,700
-27
-0% -$6.99K
SEDG icon
29
SolarEdge
SEDG
$1.95B
$16.2M 1.15%
50,317
+977
+2% +$268K
MKC icon
30
McCormick & Company Non-Voting
MKC
$14.2B
$16M 1.14%
159,843
-4,638
-3% -$453K
ADBE icon
31
Adobe
ADBE
$105B
$15.8M 1.12%
34,589
+8,639
+33% +$4.16M
CVS icon
32
CVS Health
CVS
$122B
$15.4M 1.1%
152,253
+1,774
+1% +$186K
TEL icon
33
TE Connectivity
TEL
$62.6B
$14.8M 1.05%
113,118
+2,770
+3% +$396K
ABBV icon
34
AbbVie
ABBV
$435B
$14.5M 1.03%
89,590
+3,295
+4% +$479K
DHR icon
35
Danaher
DHR
$144B
$12.7M 0.91%
49,003
-1,459
-3% -$365K
ABT icon
36
Abbott
ABT
$187B
$12.1M 0.86%
102,028
-422
-0.4% -$52.3K
MDY icon
37
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.1B
$11.5M 0.82%
23,458
-4,104
-15% -$2M
PG icon
38
Procter & Gamble
PG
$339B
$11.4M 0.81%
74,355
-2,400
-3% -$375K
IDXX icon
39
Idexx Laboratories
IDXX
$46.2B
$11.3M 0.8%
20,659
+295
+1% +$155K
VCSH icon
40
Vanguard Short-Term Corporate Bond ETF
VCSH
$45B
$10.6M 0.76%
136,272
+8,172
+6% +$650K
PEP icon
41
PepsiCo
PEP
$190B
$10.5M 0.74%
62,545
-294
-0.5% -$49.4K
TER icon
42
Teradyne
TER
$59.3B
$9.69M 0.69%
81,975
+49,611
+153% +$6.28M
IJR icon
43
iShares Core S&P Small-Cap ETF
IJR
$112B
$9.68M 0.69%
89,735
-15,264
-15% -$1.65M
CVX icon
44
Chevron
CVX
$366B
$9.53M 0.68%
58,505
-845
-1% -$121K
MCD icon
45
McDonald's
MCD
$195B
$9.26M 0.66%
37,429
-100
-0.3% -$24.9K
VXF icon
46
Vanguard Extended Market ETF
VXF
$31.9B
$9.08M 0.65%
54,833
-3,410
-6% -$561K
JPM icon
47
JPMorgan Chase
JPM
$950B
$8.69M 0.62%
63,733
+114
+0.2% +$16.8K
JMST icon
48
JPMorgan Ultra-Short Municipal Income ETF
JMST
$7.15B
$8.62M 0.61%
170,202
-15,987
-9% -$812K
VTIP icon
49
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.8B
$8.35M 0.59%
163,115
-9,257
-5% -$475K
VRP icon
50
Invesco Variable Rate Preferred ETF
VRP
$3.02B
$8.31M 0.59%
340,003
+4,286
+1% +$107K

Similar funds

Boston Family Office's Q1 2022 Portfolio in Review

As of Q1 2022, Boston Family Office held 296 positions worth $1.41B, down 8.6% from $1.54B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Boston Family Office's Q1 2022 filing shows 14 new, 84 increased, 108 reduced and 10 closed positions. Its largest new stake was Shell: 9,350 shares worth $514K. The largest sale was Apple, an estimated $6.04M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Boston Family Office's largest Q1 2022 buy was Shell: 9,350 shares worth $514K.
  • Boston Family Office added most to Teradyne in Q1 2022, an estimated $6.28M increase.
  • Boston Family Office's biggest Q1 2022 reduction was Apple, cutting an estimated $6.04M.
  • Boston Family Office fully exited Thor Industries in Q1 2022, selling an estimated $1.1M.
  • Boston Family Office's ten largest holdings make up 27% of its $1.41B portfolio in Q1 2022.
  • Boston Family Office opened 14 new positions and closed 10 in Q1 2022.
  • Boston Family Office's portfolio value fell 8.6% quarter-over-quarter to $1.41B.

Based on Boston Family Office's 13F filing for Q1 2022, filed 11 May 2022.